Resultados da pesquisa - Edgardo Rivera

  • A mostrar 1 - 12 resultados de 12
Refinar resultados
  1. 1
    Liposomal Anthracyclines in Metastatic Breast Cancer: Clinical Update

    Liposomal Anthracyclines in Metastatic Breast Cancer: Clinical Update Por Edgardo Rivera

    Publicado em 2003
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer

    Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer Por Edgardo Rivera, Mary Cianfrocca

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone

    Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone Por Edgardo Rivera, Henry Gómez

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  4. 4
    Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors

    Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors Por Edgardo Rivera, Joyce Lee, Angela M. Davies

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    Factors Associated With Participation in Breast Cancer Treatment Clinical Trials

    Factors Associated With Participation in Breast Cancer Treatment Clinical Trials Por Nancy E. Avis, Kevin Smith, Carol L. Link, Gabriel N. Hortobágyi, Edgardo Rivera

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Docetaxel secretion in tears: association with lacrimal drainage obstruction.

    Docetaxel secretion in tears: association with lacrimal drainage obstruction. Por Bita Esmaeli, Moloud Ahmadi, Edgardo Rivera, Vicente Valero, Toni Hutto, Denise M Jackson, Robert A. Newman

    Publicado em 2002
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

    Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma Por Edgardo Rivera, Christina Meyers, Morris D. Groves, Vicente Valero, Deborah Francis, Banu K. Arun, Kristine Broglio, Guosheng Yin, Gabriel N. Hortobágyi, Thomas A. Buchholz

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Phase II Trial of Anastrozole Plus Goserelin in the Treatment of Hormone Receptor–Positive, Metastatic Carcinoma of the Breast in Premenopausal Women

    Phase II Trial of Anastrozole Plus Goserelin in the Treatment of Hormone Receptor–Positive, Metastatic Carcinoma of the Breast in Premenopausal Women Por Robert W. Carlson, Richard L. Theriault, Christine M. Schurman, Edgardo Rivera, Cathie T. Chung, S. Phan, Banu K. Arun, Kristine Dice, Vivian Chiv, Marjorie Green, Vicente Valero

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer

    Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer Por Edgardo Rivera, Jaime Mejia, Banu K. Arun, Rosnie B. Adinin, Ronald S. Walters, Abenaa M. Brewster, Kristine Broglio, Guosheng Yin, Bita Esmaeli, Gabriel N. Hortobágyi, Vicente Valero

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma

    Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma Por Lajos Pusztai, Peter J. Wagner, Nuhad K. Ibrahim, Edgardo Rivera, Richard L. Theriault, Daniel J. Booser, Fraser Symmans, Franklin C. Wong, George Blumenschein, Donald R. Fleming, Roman Rouzier, G. R. Boniface, Gabriel N. Hortobágyi

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

    Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer Por Eva Thomas, Josep Tabernero, Monica Fornier, Pierfranco Conté, P. Fumoleau, Aña Lluch, Linda T. Vahdat, Craig A. Bunnell, Howard A. Burris, Patrice Viens, José Baselga, Edgardo Rivera, Valentina Guarneri, Valerie Poulart, Judith Klimovsky, David Lebwohl, Miguel Martín

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

    Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks Por Marjorie C. Green, Aman U. Buzdar, Terry Smith, Nuhad K. Ibrahim, Vicente Valero, Marguerite Rosales, Massimo Cristofanilli, Daniel J. Booser, Lajos Pusztai, Edgardo Rivera, Richard L. Theriault, Cynthia Carter, Debra Frye, Kelly K. Hunt, W. Fraser Symmans, Eric A. Strom, Ayşegül A. Şahin, William M. Sikov, Gabriel N. Hortobágyi

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: